期刊文献+

精神分裂症患者前额叶和丘脑的质子磁共振波谱研究 被引量:18

A proton magnetic resonance spectroscopy imaging study on prefrontal lobe and thalamus in patients with schizophrenia
原文传递
导出
摘要 目的探讨精神分裂症患者前额叶、丘脑的氢质子磁共振波谱(^1H-MRS)的特点。方法以38例精神分裂症患者为研究对象(患者组),以38名正常人为对照组。两组对象在入组24h内采用多体素。H-MRS检测前额叶和丘脑N-乙酰基天门冬氨酸(NAA)、胆碱复合物(Cho)与肌酸复合物(Cr),完成NAA/Cr值、Cho/Cr值和NAA/(Cho+cr)值的计算。采用t检验进行分析。结果组间比较,患者组左侧前额叶及左、右侧丘脑NAA/Cr值(分别为1.32±0.36,1.53±0.30,1.48±0.37)均低于对照组(分别为1.74±0.27,1.72±0.26,1.73±0.29),差异均有统计学意义(£检验;P均〈0.05);患者组左侧前额叶NAA/(Cho+cr)值(0.64±0.13)低于对照组(0.74±0.22),差异有统计学意义(t=2.26,P〈0.05)。组内比较,患者组和对照组的前额叶及丘脑左、右两侧各生化物质代谢指标的差异均无统计学意义(t检验;P均〉0.05)。结论精神分裂症患者存在前额叶及丘脑神经元的功能和(或)结构异常,精神分裂症患者和正常人脑部NAA、Cho、Cr可能并不存在侧化现象。 Objective To identify the metabolite levels in prefrontal lobe and thalamus in patients with schizophrenia by proton magnetic resonance spectroscopy (^1H-MRS). Methods Thirty-eighty schizophrenics and 38 normal controls were involved in this study. A multi-voxel ^1H-MRS was given to all the subjects on prefrontal lobe and thalamus within 24 hours they got in hospital. The N-acetylaspartate (NAA), choline-congtaining compounds (Cho), and creatine compounds (Cr) were measured and the ratios of NAA/Cr, Cho/Cr and NAA/( Cho + Cr) were determine& Results In left prefrontal lobe and bilateral thalamus, the NAA/Cr ratio in patients demonstrated lower than that in normal controls ( all P 〈 0.05). In left prefrontal lobe, the NAA/( Cho + Cr) ratio in patients showed lower than that in normal controls (0.64 ±0. 13 vs. 0. 74 ±0. 22,t =2. 26, P 〈0. 05). Both in patients and in normal controls, there were no significant differences in NAA/Cr, Cho/Cr and NAA/( Cho + Cr) between the two sides (all P 〉 0. 05). Conclusions Abnormalities in neuronal function and/or integrity are present in schizophrenics. There is no significantly lateralized asymmetry for metabolite levels such as NAA, Cho and Cr in either the schizophrenics or the controls.
出处 《中华精神科杂志》 CAS CSCD 北大核心 2009年第3期142-145,共4页 Chinese Journal of Psychiatry
关键词 精神分裂症 磁共振波谱学 额叶 丘脑 Schizophrenia Magnetic resonace spectroscopy Frontal lobe Thalamus
  • 相关文献

参考文献15

  • 1Najm IM, Wang Y, Hong SC, et al. Temporal changes in proton MRS metabolites after kainic acid induced seizure in rat brain. Epilepsy, 1997, 38: 87-94.
  • 2Garcia PA, Laxer KD, van der Grand J, et al. Correlation of seizure frequency with N-acetylaspartate levels determined by I H magnetic resonance spectroscopic imaging. Magn Re.sen Imaging, 1997, 15 : 475-478.
  • 3Soares JC, Innis RB. Neurochemical brain imaging investigations of schizophrenia. Biol Psychiatry, 1999, 46: 600-615.
  • 4Zimmerman RA, Wang Z. Proton magnetic spectroscopy. Crit Rev Neurosurg, 1999, 9: 161-166.
  • 5Tanaka Y, Obata T, Sassa T, et al. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction. Psychiatry Clin Neurosci, 2006, 60 : 365-372.
  • 6Ohrmann P, Siegmund A, Suslow T, et al. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study. J Psychiatr Res, 2007, 41: 625- 634.
  • 7段惠峰,甘景梨.精神分裂症不同时期磁共振质子波谱分析研究进展[J].中国神经精神疾病杂志,2008,34(3):190-192. 被引量:9
  • 8Shimizu E, Hashimoto K, Ochi S, et al. Posterior cingulate gyrus metabolic changes in chronic schizophrenia with generalized cognitive deficits. J Psychiatr Res, 2007, 1 : 49-56.
  • 9Bertolino A, Sciota D, Brudaglio F, et al. Working memory deficits and levels of N-acetylaspartate in patients with schizophreniform disorder. Am J Psychiatry, 2003, 160: 483- 489.
  • 10Tsai SJ. Central N-acetyl aspartylglutamate deficit: a possible pathogenesis of schizophrenia. Med Sci Monit, 2005, 11 : 39-45.

二级参考文献36

  • 1黄海东,邓敬兰,宦怡,杨春敏,葛雅丽,赵海涛.脑质子磁共振波谱在早期帕金森病诊断中的价值[J].实用放射学杂志,2004,20(6):486-488. 被引量:7
  • 2Pouwels PJW, Frahm J. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn Reson Med, 1998,39: 53.
  • 3Kadota T, Horinouchi T, Kuroda C. Development and aging of the cerebrum: Assessment with proton MR spectroscopy, 2001,22(2) : 128.
  • 4Danielsen ER,Ross BD. Magnetic resonance spectroscopy diagnosis of neurological diseases. New York : Marcel Dekker, 1999. 194.
  • 5Michaelis T, Merboldt KD, Bruhn H, et al. Absolute concentrations of metabolites in the adult human brain in vivo: Quantification of localized proton MR spectra.Radiology, 1993,187(1) :219.
  • 6Rudkin TM, Arnold DL. MR spectroscopy and biochemical basis of neurological disease. In : Atlas SW. Magnetic resonance imaging of the brain and spine.3rd ed.Philadelphia:Lippincott Willians & Wilkins, 2002. 2021.
  • 7Block W, Bayer TA, Tepest R, et al. Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study [J]. Neurosci Lett, 2000,289(2) :147-151.
  • 8Cecil KM, Lenkinski RE, Gur RE, et al. Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia [J]. Neuropsychopharmacology, 1999,20(2):131-140.
  • 9Gruber S, Frey R, Mlynarik V, et al. Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by ^1H-MRS at 3 Tesla [J]. Invest Radiol, 2003,38(7) :403-408.
  • 10Murphy DG, Critchley HD, Schmitz N, et al. Asperger syndrome: a proton magnetic resonance spectroscopy study of brain [J]. Arch Gen Psychiatry, 2002,59(10):885- 891.

共引文献18

同被引文献175

引证文献18

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部